Cheat sheet

FPGEE Cheat Sheet

Practice this exam

Basic Biomedical Sciences

  • 12% of exam
  • Renal CV Physiology Biochemistry Enzyme Kinetics Immunology Microbiology

Pharmaceutical Sciences

  • 31% of exam
  • Pharmacokinetics CYP450 Drug Name Stems Calculations Compounding

Social/Behavioral/Admin Sciences

  • 20% of exam
  • Controlled Substances Pharmacy Law Biostatistics Pharmacoeconomics

Pharmacy Practice & Clinical Sciences

  • 37% of exam
  • Diabetes Hypertension Infectious Disease Pulmonology Psychiatry Oncology

Quick Facts

  • Exam FPGEE
  • Questions 200
  • Time 4.5 hours
  • Pass Score 75 (scaled)
  • Format Computer, fixed-form
  • Level Foreign pharmacy graduate
  • Administrator NABP / Pearson VUE
  • Attempts 5 lifetime maximum

Antibody Response Order BI

  • IgM first responder, then IgG for memory
  • IgM: acute phase IgG: long-term memory IgA: mucosal defense IgE: allergy/parasites

Competitive vs Noncompetitive Inhibition BI

Competitive

  • Raises Km value
  • Same Vmax retained
  • Overcome by more substrate

Noncompetitive

  • Km stays same
  • Lowers Vmax value
  • Substrate cannot reverse it
  • Km shifts vs Vmax shifts

Renal & CV Physiology BI

  • PCT Reabsorbs glucose, amino acids
  • Loop of Henle Builds concentration gradient
  • ADH Signals water reabsorption
  • RAAS Regulates BP and volume
  • Normal GFR ~120 mL/min
  • Frank-Starling Preload raises stroke volume

IgE vs IgG Antibodies BI

IgE

  • Drives allergic reactions
  • Fights parasitic infection

IgG

  • Crosses the placenta
  • Provides lasting immunity
  • Allergy driver vs lasting immunity

Biochemistry & Enzyme Kinetics BI

  • Glycolysis Glucose to pyruvate
  • Krebs cycle Mitochondrial ATP production
  • Km Lower means higher affinity
  • Vmax Maximum reaction rate
  • Competitive inhibitor Raises Km, same Vmax
  • Noncompetitive inhibitor Lowers Vmax, same Km

Immunology & Microbiology BI

  • IgG Crosses the placenta
  • IgA Found in mucosal secretions
  • IgE Allergy and parasite defense
  • IgM First antibody responder
  • Gram-positive Thick peptidoglycan wall
  • Gram-negative LPS outer membrane

Common Drug Suffixes PH

  • olol beta, -pril ACE, -sartan ARB
  • olol: beta blocker -pril: ACE inhibitor -sartan: ARB -statin: cholesterol

Zero-Order vs First-Order Kinetics PH

Zero-order

  • Constant amount eliminated
  • Enzymes get saturated
  • Phenytoin, ethanol, aspirin examples

First-order

  • Constant fraction eliminated
  • Most drugs follow
  • Concentration-proportional elimination rate
  • Amount vs fraction removed

Pharmacokinetic Parameter Selection PH

  • Need distribution volume estimate → Calculate Vd
  • Need elimination rate estimate → Calculate half-life
  • Renal dose adjustment needed → Cockcroft-Gault CrCl
  • Narrow index drug dosed → Therapeutic drug monitoring
  • High-risk vancomycin dosing → AUC/MIC monitoring

Pharmacokinetic Formulas PH

  • Vd Dose divided by C0
  • Half-life 0.693 x Vd over CL
  • Cockcroft-Gault Estimates creatinine clearance
  • Steady state Reached in 4-5 half-lives
  • Loading dose Vd x target concentration
  • Maintenance dose CL x Css x tau
  • Zero-order kinetics Constant amount eliminated
  • First-order kinetics Constant fraction eliminated

Steady State Rule PH

  • Steady state reached after 4-5 half-lives
  • 4 half-lives: ~94% 5 half-lives: ~97% Same for loading/elimination

Compounding Standard Selection PH

  • Sterile IV preparation needed → Follow USP <797>
  • Nonsterile capsule or cream → Follow USP <795>
  • Hazardous chemo drug handled → Follow USP <800>
  • Checking product expiration date → Confirm beyond-use date

CYP450 & Drug Interactions PH

  • CYP3A4 Metabolizes most drugs
  • CYP2D6 Activates codeine, tramadol
  • Grapefruit juice Inhibits CYP3A4
  • Rifampin Potent CYP inducer
  • Narrow index drugs Warfarin, digoxin, lithium

USAN Drug Name Stems PH

  • olol Beta blocker
  • pril ACE inhibitor
  • sartan ARB
  • statin HMG-CoA reductase inhibitor
  • dipine Dihydropyridine CCB
  • azole Antifungal or PPI
  • floxacin Fluoroquinolone antibiotic
  • cillin Penicillin antibiotic
  • gliflozin SGLT2 inhibitor

Pharmaceutical Calculations PH

  • Alligation Mixes two strengths
  • % w/v Grams per 100 mL
  • Osmolarity mOsm solute per liter
  • Isotonic solution Equivalent to 0.9% NaCl
  • Aliquot method Dilutes very small doses

Compounding & Dosage Forms PH

  • USP <795> Nonsterile compounding standard
  • USP <797> Sterile compounding standard
  • USP <800> Hazardous drug handling
  • Enteric coating Delays release past stomach
  • Beyond-use date Compounded product expiration

Schedule II vs Schedule III-V Refills SO

Schedule II

  • No refills allowed
  • New Rx required

Schedule III-V

  • Up to 5 refills
  • Within 6 months
  • Refill rules differ by schedule

Controlled Substance Rx Rules SO

  • Schedule II refill requested → Not allowed, new Rx
  • Emergency Schedule II supply → Oral order permitted
  • Schedule III-V refill requested → Up to 5 refills
  • Suspected prescription diversion → Report per state law

Controlled Substance Schedules SO

  • Schedule I No accepted medical use
  • Schedule II High abuse, accepted use
  • Schedule III Moderate abuse potential
  • Schedule IV Low abuse potential
  • Schedule V Lowest abuse potential
  • CII prescriptions No refills allowed

Pharmacy Law Essentials SO

  • HIPAA Protects patient privacy
  • OBRA '90 Requires patient counseling
  • PPPA Child-resistant packaging law
  • DSCSA Tracks drug supply chain
  • REMS Manages high-risk drug safety

Biostatistics & Pharmacoeconomics SO

  • p-value <0.05 Statistically significant result
  • 95% CI Range of confidence
  • NNT Patients treated per benefit
  • Cost-effectiveness analysis Cost per clinical outcome
  • Cost-utility analysis Cost per QALY
  • Type I error False positive finding

Blood Pressure Stages CL

  • 120 elevated, 130 stage one, 140 stage two
  • <120/80: normal 120-129: elevated 130-139: stage 1 ≥140/90: stage 2

Trough Monitoring vs AUC/MIC CL

Trough-only (old)

  • 15-20 mcg/mL target
  • Higher nephrotoxicity risk

AUC/MIC (current)

  • 400-600 target range
  • 2020 ASHP/IDSA standard
  • AUC guides vancomycin dosing now

Drug Class Selection Logic CL

  • T2DM first-line therapy needed → Metformin
  • ASCVD risk reduction needed → High-intensity statin
  • HFrEF maintenance therapy → ACEI/ARNI plus beta-blocker
  • AFib stroke prevention needed → DOAC preferred agent
  • MRSA skin infection → Vancomycin or linezolid
  • H. pylori infection confirmed → Quadruple therapy regimen

Diabetes & Endocrine (ADA) CL

  • A1C diagnosis ≥6.5% confirms diabetes
  • Prediabetes A1C 5.7% to 6.4%
  • Fasting glucose diagnosis ≥126 mg/dL
  • Metformin First-line for T2DM
  • GLP-1/SGLT2 CV and renal benefit

ACE Inhibitor vs ARB CL

ACE inhibitor

  • Blocks ACE enzyme
  • Often causes dry cough

ARB

  • Blocks receptor directly
  • Rarely causes cough
  • Cough favors switching to ARB

Hypertension & Cardiology CL

  • Normal BP Below 120/80
  • Stage 1 HTN 130-139/80-89 mmHg
  • Stage 2 HTN 140/90 mmHg or higher
  • Warfarin INR target 2 to 3
  • Digoxin range 0.5 to 2 ng/mL
  • DOACs No routine INR monitoring

Infectious Disease & Immunizations CL

  • Vancomycin target AUC/MIC 400-600
  • CURB-65 Pneumonia severity score
  • MRSA therapy Vancomycin or linezolid
  • C. diff first-line Vancomycin or fidaxomicin
  • Live vaccines Avoid in immunosuppressed
  • Penicillin allergy Use caution with cephalosporins

Pulmonology, Psychiatry & Oncology CL

  • GOLD mild COPD FEV1 ≥80% predicted
  • GOLD severe COPD FEV1 30-49% predicted
  • SSRI First-line for depression
  • Lithium range 0.6 to 1.2 mEq/L
  • Serotonin syndrome Hyperthermia, clonus, agitation
  • Myelosuppression Common chemo dose-limiting toxicity

Common Traps

Schedule II vs III Refills

  • CII = no refills ≠ CIII-V = up to 5

Trough vs AUC Vancomycin

  • Trough alone is outdated ≠ AUC/MIC is current standard

Km vs Vmax Inhibition

  • Competitive raises Km ≠ Noncompetitive lowers Vmax

Zero-Order vs First-Order

  • Zero-order = constant amount ≠ First-order = constant fraction

IgE vs IgG Function

  • IgE drives allergy ≠ IgG gives lasting immunity

Elevated vs Stage 1 BP

  • Elevated = under 130/80 ≠ Stage 1 = 130-139/80-89

ACEI Cough vs ARB

  • ACEI often causes cough ≠ ARB rarely causes cough

Last Minute

  • 1. Weights: 12/31/20/37 percent
  • 2. 200 questions, 4.5 hours total
  • 3. Scaled passing score is 75
  • 4. Clinical Sciences is largest domain
  • 5. CII drugs are never refillable
  • 6. Vancomycin: AUC/MIC 400-600 target
  • 7. A1C of 6.5%+ confirms diabetes
  • 8. Stage 2 HTN: ≥140/90
  • 9. Km up means competitive inhibition
  • 10. First-order: constant fraction eliminated
  • 11. FPGEE offered once per year
  • 12. Maximum 5 lifetime FPGEE attempts

NABP FPGEE Foreign Pharmacy Graduate Examination

  • Practice Questions 200 questions Study Guide 42 topics Cheat Sheet 90 facts Flashcards 50 cards Videos 1 video Blogs 1 blog Free CE Podcast